 SOUTH SAN FRANCISCO, Calif., July 29, 2021 PRNewswire -- Sutro Biopharma, Inc. NASDAQ: STRO, a clinical-stage drug discovery, development and manufacturing company focused on the application of precise protein engineering and rational design to create next-generation cancer and autoimmune therapeutics, today announced that Chief Executive Officer, Bill Newell, will participate in a panel titled ADCs Take Me to Your Tumor at the 12th Annual Wedbush PacGrow Healthcare Virtual Conference on Wednesday, August 11, at 2:20 p.m. 